Form 4: Zimmer Biomet Director Syed A. Jafry Reports Acquisition of Phantom Stock Units

Director Syed A. Jafry reports acquiring phantom stock units in Zimmer Biomet Holdings, Inc. through a deferred compensation plan.

Summary

• Syed A. Jafry, a director of Zimmer Biomet Holdings, Inc., filed a Form 4 indicating changes in beneficial ownership.
• The report details the acquisition of 103.578 phantom stock units on March 31, 2024, under the Zimmer Biomet Holdings, Inc. Deferred Compensation Plan for Non-Employee Directors.
• These units were acquired at a price of $0 and are convertible to common stock on a 1-for-1 basis.
• The units will be settled in shares of company common stock within sixty days after cessation of the reporting person's service as a Director.
• Following the reported transaction, Jafry beneficially owns 5,100.769 derivative securities, including 9.305 phantom stock units accrued on January 31, 2024, under the dividend reinvestment provision of the plan.

Sentiment

Score: 6

Explanation: The sentiment is neutral as it reflects a standard transaction related to director compensation. There are no indications of positive or negative implications for the company's performance.

Positives

• The acquisition of phantom stock units aligns the director's interests with the long-term performance of the company.
• The deferred compensation plan incentivizes directors to remain engaged and contribute to the company's success.

Future Outlook

The phantom stock units will be settled in shares of company common stock within sixty days after cessation of the reporting person's service as a Director.

Industry Context

This filing is a routine disclosure related to director compensation and is typical for publicly traded companies. It reflects a component of executive compensation practices within the medical device industry.

Comparison to Industry Standards

• Deferred compensation plans are a common practice among publicly traded companies, including Zimmer Biomet's competitors such as Stryker and Johnson & Johnson.
• The use of phantom stock units is a typical method to align director compensation with shareholder value, similar to practices observed in comparable companies.
• The specific terms of the deferred compensation plan, such as the vesting schedule and settlement terms, would need to be compared to industry benchmarks to assess its competitiveness.

Stakeholder Impact

• The acquisition of phantom stock units aligns the director's interests with those of shareholders, potentially encouraging decisions that enhance long-term shareholder value.

Key Dates